The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Alexandre Chlenski and Radhika R. Peddinti.
Connection Strength

0.348
  1. Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer. 2010 Jun 04; 9:138.
    View in: PubMed
    Score: 0.095
  2. Prominent microvascular proliferation in clinically aggressive neuroblastoma. Clin Cancer Res. 2007 Jun 15; 13(12):3499-506.
    View in: PubMed
    Score: 0.077
  3. SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene. 2007 Jul 05; 26(31):4513-22.
    View in: PubMed
    Score: 0.075
  4. Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Res. 2012 Sep 15; 72(18):4714-23.
    View in: PubMed
    Score: 0.027
  5. Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth. Pediatr Blood Cancer. 2012 Oct; 59(4):642-7.
    View in: PubMed
    Score: 0.026
  6. The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth. Pediatr Blood Cancer. 2011 Jan; 56(1):164-7.
    View in: PubMed
    Score: 0.025
  7. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors. Mod Pathol. 2009 Jul; 22(7):950-8.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.